These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2001555)

  • 41. A,B blood group antigens in tissues of AB heterozygotes. Emphasis on normal and neoplastic urothelium.
    Limas C
    Am J Pathol; 1990 Nov; 137(5):1157-62. PubMed ID: 2240163
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation of the cell surface antigens with stage and grade in cancer of the bladder.
    Emmott RC; Javadpour N; Bergman SM; Soares T
    J Urol; 1979 Jan; 121(1):37-9. PubMed ID: 759641
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and ABO (H) blood group antigens on tissue sections of urinary bladder tumors].
    Fujioka T; Tanji S; Koike H; Kubo T; Ohhori T
    Hinyokika Kiyo; 1985 Oct; 31(10):1709-16. PubMed ID: 3911765
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The study of cell surface antigens in bladder tumors: ABH-isoantigen and Thomsen-Friedenreich antigen].
    Kobayashi H
    Hinyokika Kiyo; 1987 Apr; 33(4):535-44. PubMed ID: 3618425
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lewis a antigen in transitional cell tumors of the urinary bladder.
    Juhl BR; Hartzen SH; Hainau B
    Cancer; 1986 Jul; 58(2):222-8. PubMed ID: 3521828
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A, B, O (H) antigenic determinants in superficial transitional cell tumors of bladder.
    Selli C; Cozzolino F; Vercelli D; Mincione GP
    Urology; 1983 Feb; 21(2):132-4. PubMed ID: 6186066
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Isoantigens A, B and H in urinary bladder carcinomas following radiotherapy.
    Alroy J; Teramura K; Miller AW; Pauli BU; Gottesman JE; Flanagan M; Davisohn I; Weinstein RS
    Cancer; 1978 May; 41(5):1739-45. PubMed ID: 647623
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monoclonal antibodies for characterization of the heterogeneity of normal and malignant transitional cells.
    Arndt R; Dürkopf H; Huland H; Donn F; Loening T; Kalthoff H
    J Urol; 1987 Apr; 137(4):758-63. PubMed ID: 3550155
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blood group isoantigen deletion in carcinoma in situ of the urinary bladder.
    Weinstein RS; Alroy J; Farrow GM; Miller AW; Davidsohn I
    Cancer; 1979 Feb; 43(2):661-8. PubMed ID: 421187
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Altered reactivity for A, B, H antigens in transitional cell carcinomas of the urinary bladder. A study of the mechanisms involved.
    Limas C; Lange P
    Cancer; 1980 Sep; 46(6):1366-73. PubMed ID: 7417937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prognostic value of the detection of ABO surface antigens by indirect immunofluorescence technic in transitional tumors of the bladder].
    Borella T; Loro M; Dato I; Merlo F; Giudici M
    Minerva Med; 1986 Sep; 77(34-35):1527-32. PubMed ID: 3531921
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Red cell surface antigen and its relationship to survival of patients with transitional cell carcinoma of the bladder.
    Askari A; Colmenares E; Saberi A; Jarman WD
    J Urol; 1981 Feb; 125(2):182-4. PubMed ID: 7206050
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lectin binding and expression of blood group-related antigens in carcinoma-in-situ and invasive carcinoma of urinary bladder.
    Nakanishi K; Kawai T; Suzuki M
    Histopathology; 1993 Aug; 23(2):153-8. PubMed ID: 8406387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Immunofluorescence study of the distribution of ABH cell surface antigens in bladder tumours (author's transl)].
    Vallancien G; Rouger P; Leclerc JP; Kuss R
    Sem Hop; 1982 May; 58(19):1161-4. PubMed ID: 6285497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A grading system for the immunostaining of A, B and H blood group isoantigens in bladder carcinoma.
    Busch C; Malmström PU; Norlen BJ; Sällström J; Brodin T; Lundblad A
    Anticancer Res; 1988; 8(1):81-7. PubMed ID: 3358642
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A useful monoclonal antibody (BL2-10D1) to identify tumor cells in urine cytology.
    Longin A; Fontaniere B; Berger-Dutrieux N; Devonec M; Laurent JC
    Cancer; 1990 Mar; 65(6):1412-7. PubMed ID: 2407335
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blood group isoantigen and involucrin expression in cervical intraepithelial neoplasia.
    Lindgren A; Stendahl U; Nordlinder H; Busch C
    Anticancer Res; 1987; 7(2):243-6. PubMed ID: 3592638
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Specific red cell adherence test and unspecific immune response in patients with superficial bladder cancer.
    Jakse G; Hofstädter F; Märk R
    Urol Int; 1981; 36(3):171-7. PubMed ID: 7025414
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of specific red-cell adherence and immunoperoxidase staining techniques for ABO(H) blood-group cell-surface antigens on superficial transitional cell carcinoma of the bladder.
    Boileau MA; Cowles RS; Schmidt KL; Schmidt WA
    J Surg Oncol; 1985 Oct; 30(2):72-9. PubMed ID: 3908825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.